Rochester, Minnesota


rajkumar.vincent@mayo.edu Clinical Profile


  • Chair, ECOG Myeloma Committee
  • Chair, Mayo Clinic Myeloma Amyloidosis Dysproteinemia Group
  • Associate Editor, Mayo Clinic Proceedings
  • Section Editor, Leukemia
  • Phase II and III Clinical Trials in Multiple Myeloma
  • Angiogenesis in Myeloma and hematologic malignancies
  • Novel Therapy for Multiple Myeloma
  • Epidemiology and Prognosis of myeloma and related monoclonal gammopathies
I am engaged in clinical, epidemiological and laboratory research in myeloma and related disorders. I have served as the principal investigator of several clinical trials for the treatment of myeloma, including the two pivotal trials that led to the regulatory approval of thalidomide for the treatment of the disease in the United States and Europe. My laboratory interests are in the areas of angiogenesis and development of new agents for the treatment of myeloma.


See my publications


Administrative Appointment

  1. Consultant, Division of Hematology, Department of Internal Medicine
  2. Consultant, Division of Hematopathology, Department of Laboratory Medicine and Pathology

Academic Rank

  1. Professor of Medicine


  1. Fellow - Hematology & Medical Oncology Mayo Graduate School of Medicine, Mayo Clinic College of Medicine
  2. Resident - Internal Medicine University of North Dakota School of Medicine
  3. Internship Christian Medical College and Hospital
  4. Medical School Christian Medical College
  5. MB BS Madras University, Christian Medical College, Vellore

View my Pure Experts profile

Mayo Clinic Footer